Skip to main content
SpringerLink
Log in

Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitals

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

This article assesses the use and costs of blood transfusion during knee and hip surgery through a retrospective observational study of 92,223 discharged inpatients who had undergone knee or hip surgery from July 1, 2003, through June 30, 2004; a sample of US hospitals that participated in the Perspective Comparative Database™ (Premier Inc., Charlotte, NC) was used. Descriptive and multivariate analyses were performed to determine the use and costs of allogeneic blood transfusion (ABT). The average cost of ABT per user ranged from $387 (SD=$952) for red blood cells to $6585 (SD=$11,162) for cryoprecipitate. Utilization rates in the sample were as follows: antifibrinolytics, 0.14%; topical sealants, 3.24%; volume expanders, 3.89%; erythropoietin agents, 5.08%; and hypotensive anesthesia, 22.28%. Patients who were given volume expanders ($133.73, SD=$23.00,P < .01) or erythropoietin ($177.72, SD=$34.61,P < .01) had higher costs associated with ABT than did those who did not use volume expanders or erythropoietin. Patients who received hypotensive anesthesia (odds ratio [OR]=1.96; 95% confidence interval [CI], 1.87–2.06), a volume expander (OR=1.71; 95% CI, 1.57–1.85), a topical sealant (OR=1.61; 95% CI, 1.45–1.79), or an erythropoietic agent (OR=2.30; 95% CI, 2.06–2.57) had a greater likelihood of ABT. Investigators concluded that most transfusion reduction techniques are underused, or they do not reduce the burden of ABT associated with knee or hip surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts—blood transfusion.N Engl J Med. 1999; 340: 438–447.

    Article  PubMed  CAS  Google Scholar 

  2. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts—blood conservation.N Engl J Med. 1999; 340: 525–533.

    Article  PubMed  CAS  Google Scholar 

  3. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization.Transfusion. 1995; 35: 734–737.

    Article  PubMed  CAS  Google Scholar 

  4. Hillyer CD, Hart KK, Lackey DA 3rd, Lin LS, Bryan JA. Comparable safety of blood collection in “high-risk” autologous donors versus non—high-risk autologous and directed donors in a hospital setting.Am J Clin Pathol. 1994; 102: 275–277.

    PubMed  CAS  Google Scholar 

  5. Trouern-Trend JJ, Cable RG, Badon SJ, Newman BH, Popovsky MA. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse.Transfusion. 1999; 39: 316–320.

    Article  PubMed  CAS  Google Scholar 

  6. Red blood cell transfusions contaminated withYersinia enterocolitica—United States, 1991–1996— and initiation of a national study to detect bacteria-associated transfusion reactions.MMWR Morb Mortal Wkly Rep. 1997;46:553-555.

  7. Domen RE. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital.Transfusion. 1998; 38: 296–300.

    Article  PubMed  CAS  Google Scholar 

  8. Linden JV, Kruskall MS. Autologous blood: always safer?Transfusion. 1997; 37: 455–456.

    Article  PubMed  CAS  Google Scholar 

  9. Goldman M, Remy-Prince S, Trepanier A, Decary F. Autologous donation error rates in Canada.Transfusion. 1997; 37: 523–527.

    Article  PubMed  CAS  Google Scholar 

  10. Herregods L, Moerman A, Foubert L, et al. Limited intentional normovolemic hemodilution: ST-segment changes and use of homologous blood products in patients with left main coronary artery stenosis.J Cardiothorac Vasc Anesth. 1997; 11: 18–23.

    Article  PubMed  CAS  Google Scholar 

  11. Helm RE, Klemperer JD, Rosengart TK, et al. Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding.Ann Thorac Surg. 1996; 62: 1431–1441.

    Article  PubMed  CAS  Google Scholar 

  12. Kochamba GS, Pfeffer TA, Sintek CF, Khonsari S. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass.Ann Thorac Surg. 1996; 61: 900–903.

    Article  PubMed  CAS  Google Scholar 

  13. Kahraman S, Altunkaya H, Celebioglu B, Kanbak M, Pasaoglu I, Erdem K. The effect of acute normovolemic hemodilution on homologous blood requirements and total estimated red blood cell volume lost.Acta Anaesthesiol Scand. 1997; 41: 614–617.

    PubMed  CAS  Google Scholar 

  14. Gillon J, Thomas MJ, Desmond MJ. Consensus conference on autologous transfusion. Acute normovolaemic haemodilution.Transfusion. 1996; 36: 640–643.

    Article  PubMed  CAS  Google Scholar 

  15. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion.Anesth Analg. 1998; 86: 9–15.

    Article  PubMed  CAS  Google Scholar 

  16. Bezwada HP, Nazarian DG, Henry DH, Booth RE Jr. Preoperative use of recombinant human erythropoietin before total joint arthroplasty.J Bone Joint Surg Am. 2003; 85-A: 1795–1800.

    PubMed  Google Scholar 

  17. Munoz JJ, Birkmeyer NJ, Birkmeyer JD, O’Connor GT, Dacey LJ. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? A meta-analysis.Circulation. 1999; 99: 81–89.

    PubMed  CAS  Google Scholar 

  18. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.Anesth Analg. 1997; 85: 1258–1267.

    Article  PubMed  CAS  Google Scholar 

  19. Alderman EL, Levy JH, Rich JB, et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.J Thorac Cardiovasc Surg. 1998; 116: 716–730.

    Article  PubMed  CAS  Google Scholar 

  20. Rich JB. The efficacy and safety of aprotinin use in cardiac surgery.Ann Thorac Surg. 1998; 66(suppl 5): S6-S11; discussion, S18–S25.

    Article  PubMed  CAS  Google Scholar 

  21. Peters DC, Noble S. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.Drugs. 1999; 57: 233–260.

    Article  PubMed  CAS  Google Scholar 

  22. Kaspar M, Ramsay MA, Nguyen AT, Cogswell M, Hurst G, Ramsay KJ. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation.Anesth Analg. 1997; 85: 281–285.

    Article  PubMed  CAS  Google Scholar 

  23. Garcia-Huete L, Domenech P, Sabate A, Martinez-Brotons F, Jaurrieta E, Figueras J. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.Hepatology. 1997; 26: 1143–1148.

    Article  PubMed  CAS  Google Scholar 

  24. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty.Anesth Analg. 1997; 84: 839–844.

    Article  PubMed  CAS  Google Scholar 

  25. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis.Anaesth Intensive Care. 2003; 31: 529–537.

    PubMed  CAS  Google Scholar 

  26. Jansen AJ, Andreica S, Claeys M, D’Haese J, Camu F, Jochmans K. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty.Br J Anaesth. 1999; 83: 596–601.

    PubMed  CAS  Google Scholar 

  27. Veien M, Sorensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study.Acta Anaesthesiol Scand. 2002; 46: 1206–1211.

    Article  PubMed  CAS  Google Scholar 

  28. Reitman CA, Watters WC 3rd, Sassard WR. The cell saver in adult lumbar fusion surgery: a cost-benefit outcomes study.Spine. 2004; 29: 1580–1583; discussion, 1584.

    Article  PubMed  Google Scholar 

  29. Cavallieri S, Riou B, Roche S, Ducart A, Roy-Camille R, Viars P. Intraoperative autologous transfusion in emergency surgery for spine trauma.J Trauma. 1994; 36: 639–643.

    Article  PubMed  CAS  Google Scholar 

  30. Carless PA, Henry DA, Moxey AJ, O’Connell DL, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion.Cochrane Database Syst Rev. 2003(4):CD001888.

  31. Engoren M. A computer model comparing normovolemic hemodilution, hypervolemic hemodilution, and neither on intraoperative blood loss and final hematocrit.Am J Anesthesiol. 1995; 22: 229–234.

    PubMed  CAS  Google Scholar 

  32. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion.J Bone Joint Surg Am. 2000; 82: 89–100.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Premier, Inc., Charlotte, NC, USA

    Christopher M. Blanchette MA, Peter Feng Wang PhD & William Saunders PhD, MPH

  2. University of Maryland, Baltimore, MD, USA

    Christopher M. Blanchette MA

  3. Novo Nordisk Inc., Princeton, NJ, USA

    Ashish V. Joshi PhD & Peter Kruse MD, PhD

  4. Novo Nordisk A/S, Bagsvaerd, Denmark

    Mikael Asmussen MSc

Authors
  1. Christopher M. Blanchette MA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Feng Wang PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashish V. Joshi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Kruse MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mikael Asmussen MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. William Saunders PhD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blanchette, C.M., Wang, P.F., Joshi, A.V. et al. Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitals. Adv Therapy 23, 54–67 (2006). https://doi.org/10.1007/BF02850347

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850347

Keywords

Search

Navigation